Otrivine Fine Nasal Mist*

Go To

Otrivine Fine Nasal Mist

Otrivine Fine Nasal Mist*

Otrivine Fine Nasal Mist has been launched by Haleon to offer fast congestion relief with a new nozzle which creates a fine mist* for a better patient experience vs the previous device.

Last year, almost 70% of people suffered from nasal symptoms.1 Yet, in many countries, less than 1 in 2 people used nasal sprays to treat their nasal congestion.1

*new nozzle provides fine mist

How to use Otrivine Fine Nasal Mist

How to use Otrivine Fine Nasal Mist*

This video explains how to use Otrivine Fine Nasal Mist*

*New nozzle provides fine mist

Watch now

Otrivine Fine Nasal Mist*

Otrivine Fine Nasal Mist benefits and product features

Otrivine Fine Nasal Mist* has new patented† technology for comfortable congestion treatment.2-4

Product features and benefits include:2-4

  • An ergonomic design meaning it’s easier** to hold.
  • A gentle mist that reaches wide** to inflamed areas in the nose.
  • A 2x shorter nozzle length, ensuring greater comfort in the nose vs the previous device.
  • Designed not to drip in the back of the throat.

*New nozzle provides fine mist**vs. previous device†Patent number EP2654967B1

Watch now

Otrivine Fine Nasal Mist*

  • Otrivine congestion relief

    Patented† technology

    A patented† technology that delivers a fine mist* which feels comfortable and gentle in the nose.2-4

    †Patent number EP2654967B1*new nozzle provides fine mist

    Targeted congestion relief

    Benefits of fine nasal mist*

    The fine mist spray* reaches wider to inflamed areas† in the nasal cavity.4 Otrivine spray provides effective congestion relief.

    *new nozzle provides fine mist†vs previous device

    Designed not to drip at the back of the throat

    Designed not to drip at the back of the throat

    New Otrivine Nasal Mist has a lateral actuation system that produces a fine mist* and is designed not to drip down the throat.3

    The aftertaste and irritation from drippage down the throat after using nasal sprays are a couple of reasons that patients would not wish to use a nasal spray.1-3

    *new nozzle provides fine mist

  • 1-thumb action

    1-thumb action

    More comfortable and easier to use,* its 1-thumb action allows for easy and controlled administration with the push of a button2,4

    *vs the previous device

    Shorter nozle

    2x shorter nozzle length

    A shorter nozzle can feel less invasive in the nose,* increasing comfort and supporting ease of administration.3

    *vs previous device.

  • Patient blowing nose

    Clear the nose

    Before using the spray or spraying into the nostrils, clear the nose by blowing into a paper tissue. Dispose of the paper tissue appropriately.

    *New nozzle provides fine mist

    Unscrewing cap

    How to unscrew the cap

    Squeeze any two opposite sides of the protective cap with the thumb and index finger. At the same time twist the cap to open the bottle.

    Using New Otrivine Nasal Mist

    Priming the device

    How to prime the device

    If using the spray for the first time, hold the bottle with the thumb on the actuation button and prime the pump by actuating 5 times into the air.* Be careful not to spray into the eyes.

    *Once primed the pump will normally remain charged throughout regular daily treatment periods. However, if the spray is not ejected during the full actuation stroke, or if the product has not been used for longer than 7 days, the pump will need to be re-primed with 2 actuations.

    Handling the device

    How to hold the device

    To deliver a dose into the nostril, hold the bottle with the thumb on the actuation button. For a no dripping effect, stay upright and insert the short nozzle into a nostril.

    Using the spray

    How to use

    Press on the button to spray up the nostril and breathe in gently through the nose at the same time. Repeat this action in the other nostril.

    Cleaning nozzle

    After use care

    Clean and dry the nozzle before replacing the cap after each use.

    Closing the cap

    Putting the protective cap back on

    Put the protective cap back on the bottle until an audible ‘click’ is heard.

    N.B. To avoid possible spread of infection, the spray should be only used by one person.

Recommend Otrivine Fine Nasal Mist

Otrivine Fine Nasal Mist

Otrivine Fine Nasal Mist*

Otrivine Fine Nasal Mist* has new patented† technology for comfortable congestion treatment.2-4

*new nozzle provides fine mist†Patent number EP2654967B1

Otrivine Fine Nasal Mist product details

  • Product information – Otrivine Extra Dual Relief

    Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solution (xylometazoline hydrochloride, ipratropium bromide).

    Indications: Symptomatic treatment of nasal congestion and rhinorrhea in connection with common colds.

    Dosage: Adults: 1 puff in each nostril, up to 3 times daily, with at least 6 hours between doses. Maximum 3 applications daily into each nostril. Do not exceed the stated dose. Do not use for longer than 7 days. Geriatrics: Limited experience of use in patients above 70 years of age.

    Contraindications: Children and adolescents under 18 years. Known hypersensitivity to xylometazoline hydrochloride, ipratropium bromide, any of the excipients, atropine or atropine-like substances. Patients with glaucoma, rhinitis sicca, atrophic rhinitis or following trans-sphenoidal hypophysectomy or surgery exposing the dura mater.

    Warnings and precautions: Use with caution in people with: hypertension, cardiovascular disease, long QT syndrome, hyperthyroidism, diabetes mellitus, prostatic hypertrophy, bladder stenosis, pheochromocytoma, on monoamine oxidase inhibitors treatment or tri/tetra cyclic antidepressants (or have been on either within the last two weeks), on beta 2-agonist treatment, cystic fibrosis. Use with caution in patients predisposed to angle closure glaucoma, epistaxis or paralytic ileus. Immediate hypersensitivity including urticaria, angioedema and rash may occur. Caution in people sensitive to adrenergic substances. Avoid contact with eyes.

    Side effects: See SPC for full details. Very common: epistaxis. Common: dysgeusia, rhinalgia, nasal congestion, headache, nasal dryness, nasal discomfort, nausea, application site burn, dizziness, throat irritation, dry throat, dry mouth. Uncommon: insomnia, parosmia, tremor, eye irritation, dry eye, palpitations, tachycardia, nasal ulcer, sneezing, dyspepsia, fatigue, corneal oedema, cough.

    Price: £6.66 (ex. VAT)

    Legal Status: P.

    Licence Number: PL 15545/0002.

    Licence Holder: Haleon Ireland Dungarvan Limited, Knockbrack, Dungarvan, County Waterford, Ireland.

    Date of revision: December 2024

  • Product Information – Otrivine Sinusitis Relief and Otrivine Allergy Relief

    Otrivine Sinusitis Relief, 0.1% w/v Nasal Spray, Solution / Otrivine Blocked Nose Relief, 0.1% w/v Nasal Spray, Solution/ Otrivine Allergy Relief, 0.1% Nasal Spray. (Xylometazoline Hydrochloride).

    Indications:For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults, children over 12 years and the elderly: One application in each nostril up to 3 times daily. Do not exceed 3 applications daily into each nostril. Not suitable for children under 12 years.

    Contraindications: Hypersensitivity to xylometazoline. Trans-sphenoidal hypophysectomy or surgery exposing the dura mater, narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Not to be used in children aged less than 12 years.

    Warnings and precautions: Do not take for more than seven consecutive days. Use with Caution in patients showing a strong reaction to sympathomimetic agents, with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus and those taking tri and tetra-cyclic antidepressant treatment. Patients with long QT syndrome may be at increased of serious ventricular arrhythmias. Contains benzalkonium chloride, may cause irritation of the nasal mucosa.

    Side effects: See SmPC for full details. Common: Application site burning, nausea, headache, nasal dryness and nasal discomfort.

    MRSP (excl VAT): Blocked Nose Relief Freepod spray: £3.96; Allergy Relief and Sinusitis Relief Khone spray: £4.40

    Legal Status: GSL.

    Licence Number: PL 44673/0184.

    Licence Holder: Haleon UK Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, U.K.

    Date of revision: Jan 2024.

  • Product Information – Otrivine Congestion Relief 

    Otrivine Congestion Relief 0.1% Nasal Spray. (Xylometazoline Hydrochloride).

    Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults and adolescents over 12 years of age: 1 spray into each nostril, up to 3 times daily as needed. Do not exceed 3 applications daily into each nostril. Do not use in children under 12.

    Contraindications: Hypersensitivity to the active substance or to any of the excipients. Trans-sphenoidal hypophysectomy or surgery exposing the dura mater, narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Do not use in children under 12 years.

    Warnings and precautions: Do not take for more than seven consecutive days. Use with caution in patients showing a strong reaction to adrenergic substances, with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus and those taking tri and tetra-cyclic antidepressant treatment. Patients with long QT syndrome may be at increased of serious ventricular arrhythmias. This medicine contains polyoxyl hydrogenated castor oil which may cause skin reactions.

    Side effects:  See SPC for full details. Common: Application site burning, nausea, headache, nasal dryness and nasal discomfort.

    MRSP (excl VAT): £5

    Legal Status: GSL.

    Licence Number: PL 44673/0151.

    Licence Holder: Haleon UK Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, U.K.

    Date of revision: Jan 2024.

Otrivine – your Nasal Health Partner

Image of woman aged around 30 smiling

Patient profiles

Learn more about the patients who may benefit from using Otrivine Nasal Mist in our patient profiles page.

Find out more

Otrivine logo

The Otrivine range

Find out how the Otrivine range can help your patients.

Find out more

Icon for educational resources

Educational resources

Access videos and interactive content for pharmacy on respiratory health.

Find out more